Comparison of the Oral Direct Thrombin Inhibitor Ximelagatran With Enoxaparin as Prophylaxis Against Venous Thromboembolism After Total Knee Replacement

Authors:
  • CCClifford W. Colwell
    Clifford W. Colwell
  • CFCharles W. Francis
    Charles W. Francis
  • JGJeffrey S. Ginsberg
    Jeffrey S. Ginsberg
  • JWJames Whipple
    James Whipple
  • GPGary Peters
    Gary Peters

Abstract
VENOUS thromboembolism is a common complication after total knee replacement surgery. In the absence of prophylaxis, approximately 60% of patients have venographic evidence of deep vein thrombosis at hospital discharge.1 Although prophylaxis with low-molecular-weight heparin is effective and safe, approximately 30% of patients still develop deep vein thrombosis.2-5 Most of these thrombi are small, asymptomatic, and confined to the deep veins of the calf. However, the prevalence of proximal (eg, popliteal or more proximal) deep vein thrombosis, which is most frequently associated with symptomatic venous thromboembolism and fatal pulmonary embolism, is still approximately 6%,5 possibly because heparins are poor inhibitors of clot-bound thrombin.6 Moreover, low-molecular-weight heparin currently must be given by subcutaneous injection, which is inconvenient for some patients. Although oral warfarin sodium prophylaxis is convenient, frequent laboratory monitoring and dose adjustment are required, and warfarin is not as effective as low-molecular-weight heparin.3-5 Clearly, more effective and convenient prophylaxis is needed. Recently, prophylaxis with a direct thrombin inhibitor (recombinant desulfato-hirudin or desirudin), which potently inhibits clot-bound thrombin, was shown to be significantly more effective than and as safe as low-molecular-weight heparin after total hip replacement.7 However, the first dose was given immediately after spinal anesthesia and before surgery, which might increase the risk for operative bleeding and formation of spinal hematomas.8 In addition, desirudin has not been studied as prophylaxis for total knee replacement; it also must be given as a subcutaneous injection, which potentially limits its convenience.

This publication has 9 references indexed in Scilit: